GenoSure MG

GenoSure® MG is a highly accurate and sensitive genotypic HIV drug resistance test developed through the collaborative efforts of LabCorp and Monogram. The test can be performed on patient samples with viral loads as low as 500 copies/mL, and results are determined using Monogram’s proprietary database of more than 100,000 matched HIV phenotype and genotype samples.

The GenoSure MG report form includes drug resistance information for three classes of currently approved HIV drugs including nucleoside reverse transcriptase inhibitors, nonnucleoside reverse transcriptase inhibitors and protease inhibitors.

Features of GenoSure MG

  • Evaluates the HIV-1 polymerase (pol) region, including the complete protease coding region and amino acids 1-400 of reverse transcriptase.
  • Provides an assessment of drug susceptibility: sensitive, resistance possible, or resistant.
  • This test does not include drug resistance information for integrase inhibitors.

*If the assay fails on the initial attempt, HIV-1 RNA quantitation will be performed. If the result is < 500 copies/mL, the viral load will be reported and the client will be billed.